The Missing Piece

Newtopia Launches "GLP-1 Sustain" Program to Affordably Preserve and Extend Valuable Health Benefits of Novel Weight Loss Drugs

Retrieved on: 
Monday, January 29, 2024
Patient, Risk, MD, Weight loss, Health, RCT, Payment, Genetic testing, The Missing Piece, Habit, Waist, Exercise, ROI, Pharmaceutical industry

Unpublished data from the three-year RCT further indicate that the program's weight loss benefit persists for at least three years.

Key Points: 
  • Unpublished data from the three-year RCT further indicate that the program's weight loss benefit persists for at least three years.
  • At less than 1/10th the cost of these drugs, GLP-1 Sustain offers a proven, scalable, and affordable pathway to preserve the weight loss and other health benefits produced by GLP-1 medications for millions of Americans.
  • If the weight does not stay off, the expense of GLP-1s and related drugs is hard to justify.
  • But if Newtopia helps users sustain their weight loss, especially when they cycle off the drug protocol, payers, employers, and providers can begin to rationalize prescribing and funding greater access to these medications."